LifeMD

LifeMD is proud to support Digital Health New York Summit 2024! This exclusive, invite-only event brings together an elite group of founders, investors, and executives to drive healthcare innovation forward. Our CEO, Justin Schreiber will be joining a panel with Holly Lofton and Antoine Robiliard, moderated by Gabriel Perna, to discuss the ways that GLP-1s, together with technology, have evolved the weight management sector. Let’s connect if you’re attending! #DHNY24?https://lnkd.in/gaf3fQgk

Anthony Puopolo II, MD, President of LifeMD Affiliated P.C.s has been featured alongside top healthcare innovators and leaders in the H1 2024 New York Healthcare Innovation Report, published by Digital Health New York! Dr. Puopolo participated in a panel at OBESITY+HEALTH, a conference highlighting pressing topics related to obesity and weight management care with a focus on actionable solutions. Read the full report now to explore the latest trends and insights emerging within the digital health community in NY and beyond. https://go.dhny.co/h1-2024

Another company milestone: today we announced the launch of commercial health insurance acceptance for primary care services, including weight management --- making LifeMD’s high-quality care more affordable and accessible, and in turn improving clinical outcomes and patient retention rates. Read more about this exciting announcement on our IR website.

LifeMD is set to join the broad-market Russell 3000(R) Index at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution on July 1st. The annual reconstitution captures the 4,000 largest U.S. stocks as of April 30th, ranking them by total market capitalization. “This is testament to the hard work of my LifeMD colleagues and the success we’ve had in bringing affordable primary care, weight loss and other healthcare services to a growing number of patients nationwide,” said Justin Schreiber, Chairman and CEO of LifeMD. Read more on the LifeMD IR website.

Just Released: LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance The strength of our existing businesses --- highlighted by notable subscriber growth, retention, unit economics, and recent partner announcements --- coupled with newly launching product categories under RexMD --- position LifeMD for accelerated growth and profitability in the back half of 2024 and beyond. A press release with additional details has been posted to our IR website.

We are pleased to announce that Anthony Puopolo II, President, LifeMD Affiliated P.C.s, will be speaking at the upcoming inaugural Obesity+Health conference, sponsored by LifeMD and hosted by Digital Health New York. Dr. Puopolo will be joining a panel discussion on the topic of "What Does Optimal Obesity Care Look Like?" Learn more & register: https://lnkd.in/gbm_762V

Looking forward to speaking on Sunday at #ATANexus Deep Dive Session on "The Business of Telehealth: The Biggest Legal Issues You Need to Understand! My panel will discuss "Telehealth Joint Ventures, Pilots, and Collaborations." Please say hello, and we'll chat.

Today we announced a strategic partnership with Withings Health Solutions, a leader in digital health technology, becoming the first virtual primary care provider to elevate GLP-1 patient care with advanced in-home health monitoring devices, including the Body Pro 2 scale and the BPM Connect Pro blood pressure monitor. With these devices, LifeMD is setting a new standard in virtual care by providing clinicians with near real-time and actionable patient data that can drive compliance, enhance clinical decision-making, encourage preventive healthcare and, most importantly, improve long-term outcomes. Read more about this exciting announcement on our IR website.

We are excited to announce the appointment of Calum MacRae as an independent member of LifeMD’s Board of Directors. Dr. MacRae is currently the Vice Chair for Scientific Innovation at the Department of Medicine at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, an Associate Member of the Broad Institute of Harvard and MIT and a Principal Faculty Member at the Harvard Stem Cell Institute. Dr. MacRae brings deep clinical experience in cardiology and chronic care management that will be valuable as we look to provide innovative solutions to improve the delivery of virtual healthcare services. Check out our release for more background on Dr. MacRae!

LifeMD is pleased to sponsor the inaugural Obesity+Health conference, May 14 @ NYU and hosted by Digital Health New York. The day will be spent highlighting pressing topics related to obesity and weight management care with a focus on actionable solutions. Offering open dialogue and trusted content, the event will bring together 100+ leaders from top employers, digital health companies, investors, payers, providers and pharmaceutical companies. Learn more & register: https://lnkd.in/gbm_762V?